StonvexLoading…
StonvexStonvexStonvexCore line items from CTNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $50.00M |
Operating Income | $-50.89M | $-33.85M | $-20.87M | $16.08M |
Net Income | $-42.26M | $-27.69M | $-9.01M | $22.72M |
EPS (Diluted) | $-2.18 | $-1.61 | $-1.35 | $0.08 |
Total Assets | $212.85M | $216.03M | $221.35M | $130.39M |
Total Liabilities | $14.78M | $5.81M | $3.85M | $5.70M |
Cash & Equivalents | $21.94M | $40.89M | $77.23M | $15.53M |
Free Cash Flow OCF − CapEx | $-33.36M | $-22.99M | $-16.74M | $18.93M |
Shares Outstanding | 19.35M | 17.18M | 12.86M | 2.35M |